Summary
Previous studies have demonstrated that short course perioperative antibiotic prophylaxis reduces septic morbidity after hysterectomy from up to 40% down to 10 to 15%. The residual morbidity is predominantly urinary tract infection (UTI) occurring 2 to 3 days after cessation of antibiotic. We hypothesised that surgery impairs urinary drainage for 3 to 4 days postoperatively and that prolonged prophylaxis was required to prevent all postoperative sepsis.
Accordingly, 224 abdominal and 69 vaginal hysterectomy patients were randomly allocated to short course (2g cefotaxime IV at anaesthesia) or long course (2g cefotaxime at anaesthesia plus 7 doses of 1g 12- hourly) prophylaxis. UTI was effectively prevented by the long course (0.9 vs 18.4% short); both treatments effectively prevented wound and pelvic sepsis. We conclude that 4 days of postoperative antibiotic is required to prevent UTI.
Similar content being viewed by others
References
Dicker RC, Greenspan JR, Strauss LT, Cowart MR, Scally MJ, et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. American Journal of Obstetrics and Gynaecology 144: 841–848, 1982
Gordon DL, McDonald PJ, Bune A, Marshall VR, Grime B, et al. Diagnostic criteria and natural history of catheter-associated urinary tract infections after prostatectomy. Lancet 2: 1269–1271, 1983
Hirschmann JV, Inui TS. Antimicrobial prophylaxis: a critique of recent trials. Reviews of Infectious Diseases 2: 1–21, 1980
McDonald PJ, Sanders T, Higgins G, Finlay-Jones L, Hakendorf M, et al. Antibiotic prophylaxis in hysterectomy — cefotaxime compared to ampicillin-tinidazole. Journal of Antimicrobial Chemotherapy 14 (Suppl. B): 223–230, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McDonald, P.J., Sanders, R., Turnidge, J. et al. Optimal Duration of Cefotaxime Prophylaxis in Abdominal and Vaginal Hysterectomy. Drugs 35 (Suppl 2), 216–220 (1988). https://doi.org/10.2165/00003495-198800352-00048
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800352-00048